Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19
Pharmacology Research & Perspectives · 2023
DOI: 10.1002/prp2.1083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2023. Verfasst von Rodolfo Pedro Rothlin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sociedad Argentina de Farmacología Clínica, Asociación Médica Argentina, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: COVID-19, Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sociedad Argentina de Farmacología Clínica, Asociación Médica Argentina, Buenos Aires, Argentina.
- Servicio de Anatomía Patológica, Hospital de Alta Complejidad El Calafate SAMIC, Santa Cruz, Argentina.
- Laboratorio de Hipertensión, División de Cardiología, Hospital de Clínicas "José de San Martín", Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
- Segunda Cátedra de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
- División de Cardiología, Hospital Español de Buenos Aires, Buenos Aires, Argentina.
- Sección de Tecnología Educativa e Informática Médica, Hospital de Clínicas "José de San Martín", Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
ORCID-Profile: Rodolfo Pedro Rothlin
Zitieren
APA
Rothlin, R. P., Pelorosso, F. G., Duarte, M., Nicolosi, L., Ignacio, F. C., Salgado, M. V., & Vetulli, H. (2023). Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1083
Vancouver
Rothlin RP, Pelorosso FG, Duarte M, Nicolosi L, Ignacio FC, Salgado MV, et al. Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19. Pharmacology Research & Perspectives. 2023. doi:10.1002/prp2.1083
BibTeX
@article{Rothlin2023,
author = {Rothlin, Rodolfo Pedro and Pelorosso, Facundo Germán and Duarte, Mariano and Nicolosi, Liliana and Ignacio, Fernandez Criado and Salgado, María Victoria and Vetulli, Héctor},
title = {Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19},
journal = {Pharmacology Research & Perspectives},
year = {2023},
doi = {10.1002/prp2.1083}
}
EUVIMED